Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer
Clinical trial NCT03643510 · COMPLETED
Trial details
- NCT number
- NCT03643510
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-21
- Primary completion
- 2026-03-12
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.